Clinical outcomes of antimicrobial lock solutions used in a treatment modality: A retrospective case series analysis

Clinical Pharmacology: Advances and Applications

Volumn 2, Issue 1, 2010, Pages 123-130

  Brandon Bookstaver, P ^a   Gerrald, Katherine R ^b   Moran, Robert R ^c  

^a UNIVERSITY OF SOUTH CAROLINA COLLEGE OF PHARMACY   (United States)

^b UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

^c UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Antimicrobial lock therapy; Bacteremia; Central line associated bloodstream infection; Central venous catheter

Indexed keywords

ALCOHOL; BETA LACTAM ANTIBIOTIC; CEFAZOLIN; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CLINDAMYCIN; DAPTOMYCIN; GENTAMICIN; HEPARIN; LEVOFLOXACIN; METRONIDAZOLE; PIPERACILLIN PLUS TAZOBACTAM; RIFAMPICIN; TIMENTIN; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ANTIMICROBIAL LOCK THERAPY; ANTIMICROBIAL THERAPY; ARTICLE; BLOOD CULTURE; CASE STUDY; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CHILD; CLINICAL ARTICLE; CLINICAL EVALUATION; DRUG EFFICACY; HUMAN; INFANT; INSTRUMENT STERILIZATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; RECURRENT INFECTION; RETROSPECTIVE STUDY; SALVAGE THERAPY; SCHOOL CHILD; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS INFECTION; SYSTEMIC THERAPY; TOTAL PARENTERAL NUTRITION; TREATMENT DURATION;

EID: 77955488171     PISSN: None     EISSN: 11791438     Source Type: Book Series    
DOI: None     Document Type: Article

References (31)

1. Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the infectious diseases society of America. Clin Infect Dis. 2009;49:1249-1272.
2. Pittet D, Tarara D, Wenzel R P. Nosocomial bloodstream infection in critically ill patients: excess length of stay, extra costs, and attributable mortality. JAMA. 1994;271:1598-1601.
3. Bestul MB, VandenBussche HL. Antibiotic lock technique: review of the literature. Pharmacotherapy. 2005;25:211-227.
4. Pascual A, de Arellano ER, Martinez LM, Perea EJ. Effect of polyurethane catheters and bacterial biofilms on the in-vitro activity of antimicrobials against Staphylococcus epidermidis. J Hosp Infect. 1993;24:211-218.
5. Infectious Diseases Society of America Emerging Infections Network Report for Query. Antimicrobial lock prophylaxis and treatment of catheter-related bloodstream infections. http://www.int-med.uiowa.edu/research/ein/ALT_comments. Accessed December 10, 2008.
6. Krishnasami Z, Carlton D, Bimbo L, et al. Management of hemodialysis catheter-related bacteremia with an adjunctive antibiotic lock solution. Kidney Int. 2002;61:1136-1142.
7. Fernandez-Hildago N, Almirante B, Calleja R, et al. Antibiotic-lock therapy for long-term intravascular catheter-related bacteraemia: results on an open, non-comparative study. J Antimicrob Chemother. 2006;57:1172-1180.
8. Maya ID, Carlton D, Estrada E, Allon M. Treatment of dialysis catheter-related Staphylococcus aureus bacteremia with an antibiotic lock: a quality improvement report. Am J Kidney Dis. 2007;50:289-295.
9. Rjinders BJ, Van Wijngaerden E, Vandecasteele SJ, Stas M, Peetermans WE. Treatment of long-term intravascular catheter-related bacteraemia with antibiotic lock: randomized, placebo-controlled trial. J Antimicrob Chemother. 2005;55:90-94.
10. Fortun J, Grill F, Martin-Davila P, Blazquez J, et al. Treatment of longterm intravascular catheter-related bacteraemia with antibiotic-lock therapy. J Antimicrob Chemother. 2006;58:816-821.
11. Poole C V, Carlton D, Bimbo L, Allon M. Treatment of catheter-related bacteraemia with an antibiotic lock protocol: effect of bacterial pathogen. Nephrol Dial Transplant. 2004;19:1237-1244.
12. Kim SH, Kang CI, Kim HB, et al. Outcomes of Hickman catheter salvage in febrile neutropenic cancer patients with Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol. 2003;24:897-904.
13. Sanchez-Munoz A, Aguado JM, Lopez-Martin A, et al. Usefulness of antibiotic-lock technique in management of oncology patients with uncomplicated bacteremia related to tunneled catheters. Eur J Clin Microbiol Infect Dis. 2005;24:291-293.
14. Broom J, Woods M, Allworth A, et al. Ethanol lock therapy to treat tunneled central venous catheter-associated blood stream infections: results from a prospective trial. Scand J Infect Dis. 2008;40:399-406.
15. Onder AM, Chandar J, Billings AA, et al. Comparison of early versus late use of antibiotic locks in the treatment of catheter-related bacter-emia. Clin J Am Soc Nephrol. 2008;3:1048-1056.
16. Safdar N, Maki DG. Use of vancomycin-containing lock or flush solutions for prevention of bloodstream infection associated with central venous access devices: a meta-analysis of prospective, randomized trials. Clin Infect Dis. 2006;43:474-484.
17. Sherertz RJ, Boger MS, Collins CA, Mason L, Raad II. Comparative in vitro efficacies of various catheter lock solutions. Antimicrob Agents Chemother. 2006;50:1865-1868.
18. Raad I, Hachem R, Tcholakian K, Sherertz R. Efficacy minocycline and EDTA lock solution in preventing catheter-related bacteremia, septic phlebitis, and endocarditis in rabbits. Antimicrob Agents Chemother. 2002;46:327-332.
19. Curtin J, Cormican M, Fleming G, Keelehan J, Colleran E. Linezolid compared with eperezolid, vancomycin, and gentamicin in an in vitro model of antimicrobial lock therapy for Staphylococcus epidermidis central venous catheter-related biofilm infections. Antimicrob Agents Chemother. 2003;47:3145-3148.
20. Mohamed JA, Huang DB. Biofilm formation by enterococci. J Med Microbiol. 2007;56(Pt 12):1581-1588.
21. Falagas ME, Kaspaskelis AM, Kouranos VD, Kakisi OK, Athanassa Z, Karageorgopoulos DE. Outcome of antimicrobial therapy in documented biofilm-associated infections: a review of the available clinical evidence. Drugs. 2009;69:1351-1361.
22. LaPlante KL, Mermel LA. In vitro activity of daptomycin and vancomycin lock solutions on staphylococcal biofilms in a central venous catheter model. Nephrol Dial Transplant. 2007;22:2239-2246.
23. Bookstaver PB, Williamson JC, Tucker BK, Raad II, Sherertz RJ. Activity of novel antibiotic lock solutions in a model against isolates of catheter-related bloodstream infections. Ann Pharmacother. 2009;43:210-219.
24. Raad I, Hanna H, Jiang Y, et al. Comparative activity of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm. Antimicrob Agents Chemother. 2007;51:1656-1660.
25. Dannenberg C, Bierbach U, Rothe A, Beer J, Korholz D. Ethanol-lock technique in the treatment of bloodstream infections in pediatric oncology patients with broviac catheter. J Ped Hematol Oncol. 2003; 25:616-621.
26. Maiefski M, Rupp ME, Hermsen ED. Ethanol lock technique: review of the literature. Infect Control Hosp Epidemiol. 2009;30:1096-1108.
27. Nori US, Manoharan A, Yee J, Besarab A. Comparison of low-dose gentamicin with minocycline as catheter lock solutions in the prevention of catheter-related bacteremia. Am J Kidney Dis. 2006; 48:596-605.
28. Bleyer AJ, Mason L, Russel G, Raad II, Sherertz R. A randomized, controlled trial of a new vascular catheter flush solution (minocycline-EDTA) in temporary hemodialysis access. Infect Control Hosp Epidemiol. 2005;26:520-524.
29. Dogra GK, Herson H, Hutchison B, et al. Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate: a randomized controlled study. J Am Soc Nephrol. 2002;13:2133-2139.
30. Gray G W, Wilkinson SG. The effect of ethylenediaminetetra-acetic acid on the cell walls of some gram-negative bacteria. J Gen Microbiol. 1965; 39:385-399.
31. Banin E, Brady KM, Greenberg E P. Chelater-induced dispersal and killing of Pseudomonas aeruginosa cells in a biofilm. Appl Environ Microbiol. 2006;72:2064-2069.